Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment

por Nel, I, Gauler, T C, Eberhardt, W E, Nickel, A-C, Schuler, M, Thomale, J, Hoffmann, A-C
Publicado 2013

Attenuation of the ELAV1-like protein HuR sensitizes adenocarcinoma cells to the intrinsic apoptotic pathway by increasing the translation of caspase-2L

por Winkler, C, Doller, A, Imre, G, Badawi, A, Schmid, T, Schulz, S, Steinmeyer, N, Pfeilschifter, J, Rajalingam, K, Eberhardt, W
Publicado 2014

Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier

por Aigner, C., Brüning, T., Eberhardt, W. E. E., Härter, M., Kaelberlah, H.-P., Metzenmacher, M., Shah, R., Taube, C., Thomas, M.
Publicado 2021

Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II tria...

por Eberhardt, W, Stamatis, G, Stuschke, M, Wilke, H, Müller, M R, Kolks, S, Flasshove, M, Schütte, J, Stahl, M, Schlenger, L, Budach, V, Greschuchna, D, Stüben, G, Teschler, H, Sack, H, Seeber, S
Publicado 1999

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

por Christoph, D C, Kasper, S, Gauler, T C, Loesch, C, Engelhard, M, Theegarten, D, Poettgen, C, Hepp, R, Peglow, A, Loewendick, H, Welter, S, Stamatis, G, Hirsch, F R, Schuler, M, Eberhardt, W E E, Wohlschlaeger, J
Publicado 2012

1164P Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)

por Sebastian, M., Griesinger, F., von der Heyde, E., Dörfel, S., Wiegand, J.H., Schiefer, C., Losem, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Dietel, C., Bleckmann, A., Benkelmann, R., Boesche, M., Grah, C., Müller, A., Eberhardt, W.E.E., Thomas, M.
Publicado 2022

SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced o...

por Soria, J -C, Fülöp, A, Maciel, C, Fischer, J R, Girotto, G, Lago, S, Smit, E, Ostoros, G, Eberhardt, W E E, Lishkovska, P, Lovick, S, Mariani, G, McKeown, A, Kilgour, E, Smith, P, Bowen, K, Kohlmann, A, Carlile, D J, Jänne, P A
Publicado 2017

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

por Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R
Publicado 2015